PATENT CLAIM ANALYSIS

Application Number: 16201117
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-08
Patent Classification: ["546", "200000"]

Abstract:
The invention provides novel asymmetric and symmetric bisaminoquinolmes and related compounds, methods of treatment and syntheses. The novel compounds exhibit effective anticancer activity and are useful in the treatment of a variety of autophagy-related disorders.

Claim (Index 15):
The composition according to  claim 14  wherein L is a (poly)ethylene glycol group having from 1 to 20 ethylene glycol units optionally substituted at one or both distal ends of said (poly)ethylene glycol group with an A group or wherein L is a linear group containing from 1 to 5 non-contiguous amine groups N\u2014R\u2033, each amine group being separated from an adjacent amine group by an alkylene group containing 1, 2, 3, 4, 5, 6, 7, or 8 methylene groups or an ethylene glycol containing group containing 1, 2, 3, 4, 5 or 6 ethylene glycol units.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 98.0
- Lexical Diversity: 1.35714
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15502330', '15384823', '15890040', '15580978', '14396956']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7903680761156875
- 35 USC 102 Novelty (BERT): 0.6226092007399673
- Combined Prediction Score: 0.7735921885781155
- Mean Citation Score: 356.153908
- Max Citation Score: 619.825
- Similarity Product: 513.730924011767

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test